May 15, 2024 04:19 AM EDTUpdated 02:38 PM
People

Bio­Marin to lay off 170 staffers af­ter pipeline re­org

Reynald Castañeda

Deputy Editor

Less than a month af­ter re­veal­ing pipeline cuts amid dis­ap­point­ing gene ther­a­py sales, Bio­Marin is now down­siz­ing its team.

The biotech said it will lay …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA de­tails new 'plat­form tech­nol­o­gy' process that could ac­cel­er­ate cell and gene ther­a­py ap­provals

J&J makes an­oth­er I&I ac­qui­si­tion with $1.25B deal for Num­ab's Yel­low Jer­sey

Take­da to lay off 640 work­ers in Mass­a­chu­setts as part of mul­ti­year over­haul

In­smed stock sky­rock­ets on Phase 3 lung dis­ease da­ta

GLP-1 pre­scrip­tions reach all-time high as Lil­ly and No­vo scram­ble to keep pace with de­mand

sponsored

A nov­el study in­sight an­a­lyt­ics (SIA) method­ol­o­gy im­proves PANSS da­ta qual­i­ty and sig­nal de­tec­tion in a glob­al ...

A service from the Financial Times